C25H21F2N7O3S — CID 134461362
(3S)-3-[[5-[2-(difluoromethyl)-5-morpholin-4-yl-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one (PubChem CID 134461362) has the molecular formula C25H21F2N7O3S and a molecular weight of 537.55 g/mol. Its IUPAC name is (3S)-3-[[5-[2-(difluoromethyl)-5-morpholin-4-yl-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one.
| Compound Name | (3S)-3-[[5-[2-(difluoromethyl)-5-morpholin-4-yl-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one |
|---|---|
| PubChem CID | 134461362 |
| Molecular Formula | C25H21F2N7O3S |
| Molecular Weight | 537.55 g/mol |
| Exact Mass | 537.14 |
| IUPAC Name | (3S)-3-[[5-[2-(difluoromethyl)-5-morpholin-4-yl-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one |
| SMILES | O=C1Nc2ccccc2C(c2ccccc2)=N[C@@H]1Nc1nnc(-c2nc(C(F)F)sc2N2CCOCC2)o1 |
| InChI | InChI=1S/C25H21F2N7O3S/c26-19(27)23-30-18(24(38-23)34-10-12-36-13-11-34)22-32-33-25(37-22)31-20-21(35)28-16-9-5-4-8-15(16)17(29-20)14-6-2-1-3-7-14/h1-9,19-20H,10-13H2,(H,28,35)(H,31,33)/t20-/m1/s1 |
| InChIKey | WYDMDWJSHAYNHE-HXUWFJFHSA-N |
| XLogP | 4.20 |
| TPSA | 117.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 537.55 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |